WO2024042376 - FORMULATION OF ANALGESIC AND ANTI-INFLAMMATORY OINTMENT CONTAINING THE LEPTUCIN, MCD AND ADOLAPINE PEPTIDES
National phase entry is expected:
Publication Number
WO/2024/042376
Publication Date
29.02.2024
International Application No.
PCT/IB2023/053414
International Filing Date
04.04.2023
Title **
[English]
FORMULATION OF ANALGESIC AND ANTI-INFLAMMATORY OINTMENT CONTAINING THE LEPTUCIN, MCD AND ADOLAPINE PEPTIDES
[French]
FORMULATION DE POMMADE ANALGÉSIQUE ET ANTI-INFLAMMATOIRE CONTENANT LES PEPTIDES LEPTUCINE, MCD ET ADOLAPINE
Applicants **
BEIHAGHI, Maria
floor 3 no 143 between 21 and 23 naser khosro st naser khosro bolivar ahmad abad
Mashhad, 9176845739, IR
Inventors
TEHRANI, Ilia
no 1 besat 8 alley besat st
Sabzevar, 9618634853, IR
BAHRAMNIA GHOJEHBIGLOU, Vahid
no 321 the corner of the intersection of 16 and 20 meters nistan town
Ardabil, 5615944730, IR
BAHRAMNIA GHOJEHBIGLOU, Saeed
no 321 the corner of the intersection of 16 and 20 meters nistan town
Ardabil, 5615944730, IR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 868 | |
| EPO | Filing, Examination | 4915 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 482 | |
| USA | Filing, Examination | 6235 |
Total: 13031 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The formulation of the analgesic and anti-inflammatory ointment includes Adolapine and MCD peptides from bee venom as well as Leptucin peptide from Hemiscorpius lepturus scorpion venom, along with olive oil and fillers (Eucerin, lanolin, honey base), moisturizing agents (alexin), absorbing agents (aloe vera juice), penetrants (salicylic acid or alginate), as well as supplements (shikonin from Acium or levisticum). This work can be generated as sprays, ointments, hydrogel pads, and other therapeutic products. The use of this ointment includes regulating the cell cycle and the many cytokines involved in this cycle, as well as activating the relevant genes. Three courses are required to complete a full recovery. Depending on whether it is used topically or through injection, the amount consumed and the percentage of use vary.[French]
L'invention concerne une formulation de pommade analgésique et anti-inflammatoire qui comprend les peptides adolapine et MCD provenant du venin d'abeille ainsi que le peptide leptucine provenant du venin de scorpion Hemiscorpius lepturus, ainsi que de l'huile d'olive et des charges (eucérine, lanoline, base de miel), des agents hydratants (alexine), des agents absorbants (jus d'aloe vera), des agents de pénétration (acide salicylique ou alginate), ainsi que des compléments (shikonine provenant d'Acium ou de Levisticum). Ce composé peut être produit sous la forme de pulvérisations, de pommades, de tampons d'hydrogel et d'autres produits thérapeutiques. L'utilisation de cette pommade comprend la régulation du cycle cellulaire et des nombreuses cytokines impliquées dans ce cycle, ainsi que l'activation des gènes pertinents. Trois applications sont nécessaires pour obtenir une récupération complète. Selon qu'il est utilisé par voie topique ou par injection, la quantité consommée et le pourcentage d'utilisation varient.